跳转至内容
Merck

775118

Sigma-Aldrich

硼烷二甲基硫醚络合物 溶液

greener alternative

1.0 M in 2-methyltetrahydrofuran

别名:

BMS, 三氢 [硫代双 [甲烷]] 硼

登录查看公司和协议定价


About This Item

线性分子式:
(CH3)2S · BH3
CAS号:
分子量:
75.97
Beilstein:
3663489
MDL號碼:
分類程式碼代碼:
12352112
PubChem物質ID:
NACRES:
NA.22

形狀

liquid

反應適用性

reagent type: reductant

環保替代產品特色

Safer Solvents and Auxiliaries
Use of Renewable Feedstocks
Inherently Safer Chemistry for Accident Prevention
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

濃度

1.0 M in 2-methyltetrahydrofuran

密度

0.844 g/mL at 25 °C

官能基

thioether

環保替代類別

儲存溫度

2-8°C

SMILES 字串

B.CSC

InChI

1S/C2H6S.BH3/c1-3-2;/h1-2H3;1H3

InChI 密鑰

RMHDLBZYPISZOI-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product, 1.0 M in 2-methyltetrahydrofuran aligns with "Safer Solvents and Auxiliaries", "Use of Renewable Feedstocks" and "Inherently Safer Chemistry for Accident Prevention". Find details here.

應用

用作区域选择性还原剂的反应物

涉及的反应物:
  • 硼氢化/氧化
笼状化合物的合成
Commonly used in hydroboration of olefins and as a reductant of carbonyls. 2-Me-THF has shown potential as an environmentally friendly solvent compared to commonly used solvents; e.g. dichloromethane and THF.
For an alternative to Tetrahydrofuran and Dichloromethane, please see: An alternative to Tetrahydrofuran and Dichloromethane

包裝

The 25 mL Sure/Seal bottle is recommended as a single-use bottle. Repeated punctures will likely result in decreased performance of product.

法律資訊

Sure/Seal is a trademark of Sigma-Aldrich Co. LLC

訊號詞

Danger

危險分類

Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 2 - Repr. 1B - Skin Irrit. 2 - Water-react 1

安全危害

儲存類別代碼

4.3 - Hazardous materials which set free flammable gases upon contact with water

水污染物質分類(WGK)

WGK 2

閃點(°F)

9.3 °F

閃點(°C)

-12.6 °C


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Jeong Won Jang et al.
Hepatology (Baltimore, Md.), 61(6), 1809-1820 (2015-01-30)
The effect of viral suppression on long-term disease outcome after decompensation in patients with hepatitis B virus (HBV)-related cirrhosis has not been established. The aim of this study was to determine the long-term effect of antiviral therapy (AVT) in patients
Elin S Gray et al.
Oncotarget, 6(39), 42008-42018 (2015-11-03)
Repeat tumor biopsies to study genomic changes during therapy are difficult, invasive and data are confounded by tumoral heterogeneity. The analysis of circulating tumor DNA (ctDNA) can provide a non-invasive approach to assess prognosis and the genetic evolution of tumors
Santiago Palacio et al.
International journal of stroke : official journal of the International Stroke Society, 10(5), 686-691 (2013-05-23)
It remains controversial whether dual antiplatelet therapy reduces stroke more than aspirin alone. We aimed to assess the effects of adding clopidogrel to aspirin on the occurrence of stroke and major haemorrhage in patients with vascular disease. Meta-analysis of published
Isidoro González-Álvaro et al.
Rheumatology (Oxford, England), 54(7), 1200-1209 (2014-12-21)
The aim of this study was to establish guidelines for the optimization of biologic therapies for health professionals involved in the management of patients with RA, AS and PsA. Recommendations were established via consensus by a panel of experts in
Saskia Ditisheim et al.
Inflammatory bowel diseases, 21(11), 2598-2604 (2015-08-06)
Inflammatory bowel diseases (IBD) are systemic conditions that commonly display extraintestinal manifestations. Inflammatory articular disease (IAD: axial or peripheral) is the most common extraintestinal manifestation. The aim of this study was to evaluate the prevalence and the clinical characteristics associated

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门